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Abstract
To elucidate the mechanism of anti-lipolytic action of insulin in rat epididymal adipocytes, we explored the potential
 .mechanism that might be involved in the hormone-dependent stimulation of cAMP phosphodiesterase PDE kinase. PDE
kinase was assayed in a cell-free system. Both wortmannin and LY294002, highly specific inhibitors of phosphatidylinositol
3-kinase, almost completely blocked the hormonal effect not only on PDE kinase but also on mitogen-activated protein
 .MAP kinase. Neither PD98059, a specific inhibitor of MAP kinase, nor rapamycin, a potent inhibitor of insulin-dependent
 S6K .stimulation of p70 ribosomal protein S6 kinase p70 , had inhibitory effect on that of PDE kinase. These results are
 . S6Kconsistent with the view that i insulin-activated PDE kinase as well as MAP kinase and p70 are localized downstream
 . S6K  .of phosphatidylinositol 3-kinase, ii PDE kinase is distinct from either MAP kinase or p70 and iii PDE kinase does not
exist downstream of either MAP kinase or p70S6K. It is suggested that PDE kinase and MAP kinase or p70S6K may be
localized in separate branches of the cascade of insulin action. The branching point of the cascade could be either at or
below the level of phosphatidylinositol 3-kinase. q 1998 Elsevier Science B.V.
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1. Introduction
Anti-lipolysis is a major metabolic effect of insulin
involving dephosphorylation and concomitant deacti-
w xvation of hormone-sensitive lipase 1 . Based on their
w xstudies with inhibitors, Makino et al. 2 and Elks and
w xManganiello 3 concluded that insulin-dependent
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 .stimulation of cAMP phosphodiesterase PDE in-
duced a decline in the cellular level of cAMP and
caused dephosphorylation of the lipase, resulting in
anti-lipolysis. It was shown earlier that insulin re-
duces cAMP concentration in the liver and adipocytes
wby stimulating a membrane-bound, low-K PDE 4–m
x6 . This PDE appears to be stimulated by insulin as a
result of phosphorylation. This view was initially put
forth on the basis of the observations that the same,
membrane-bound PDE is activated by both insulin
0167-4889r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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w xand isoproterenol or cAMP 7–9 . Subsequently,
w xDegerman et al. 10 reported that insulin stimulates
phosphorylation of PDE in intact adipocytes at cer-
w x w xtain serine residues 11 . Shibata et al. 12 found that
PDE is stimulated by the incubation of cells with
okadaic acid, a potent phosphatase inhibitor. More
w xrecently, Smith et al. 13 presented their preliminary
data, indicating that the cytosol fraction extracted
from insulin-treated rat liver induces phosphorylation
of PDE in a cell-free system. These earlier studies
imply that PDE is phosphorylated by an insulin-
stimulated PDE kinase, although the latter is yet to be
isolated.
Until recently, the above anti-lipolytic mechanism
was generally thought to be localized downstream of
 .phosphatidylinositol 3-kinase PI 3-kinase in the cas-
cade of insulin action since a low concentration of
wortmannin, a highly specific inhibitor of PI 3-kinase
w x14 , strongly inhibits hormonal effects on lipolysis
w x w x14 , PDE and PDE kinase 15 . Wortmannin also
inhibits the activation of MAP kinase pathway by
w x w xinsulin 16–18 and Cross et al. 16 suggested that a
site of action of wortmannin might be found between
Ras and Raf in the upper stream of MAP kinase. This
view was recently challenged, however, by the obser-
vations that this kinase, according to Cheatham et al.
w x19 , does not appear to lie downstream of PI 3-kinase.
Therefore, it is not clear at present if the anti-lipolytic
mechanism is localized downstream of PI 3-kinase or
MAP kinase.
In our present study, we first established the
method of cell-free assay of PDE kinase from rat
epididymal adipocytes; subsequently, we investigated
 . S6Ki how PDE kinase, MAP kinase and p70 might
be localized in the cascade of insulin action in
 .adipocytes, and ii which protein kinase or kinases
might be considered to exist in the upper stream of
PDE and PDE kinase.
2. Experimental procedures
2.1. Materials
A preparation of polyclonal antibodies of PDE
rabbit serum, referred to as anti-PDE antibody in this
.report was custom-made at Japan Immuno Research
 .Laboratories Takasaki, Japan against a synthetic
peptide referred to as PDE peptide, LHNNHETET-
KADSDARL. The sequence of this peptide is identi-
cal to that of amino acids Nos. 745–761 in PDE, as
w xdeduced by Taira et al. 20 from the sequence of rat
adipocyte PDE cDNA. Anti-MAP kinase antibody
was obtained from Upstate Biotechnology Lake
. S6KPlacid, NY . Anti-p70 antibody was from Santa
 .Cruz Biotechnology Santa Cruz, CA . Carrier-free
w32 x w 32 x w3 xP orthophosphate, g- P ATP and H cAMP
were obtained from Amersham International
 .Buckinghamshire, England . Insulin was a gift from
 .Eli Lilly Indianapolis, IN . Epidermal growth factor
 . EGF was from Upstate Biotechnology Lake Placid,
.  .NY . Insulin like growth factor-I IGF-I was a gift
 .from Fujisawa Pharmaceutical Tokyo, Japan . Wort-
 .mannin was from Kyowa Medix Tokyo, Japan ,
LY294002 was from BIOMOL Research Laborato-
 .ries Plymouth Meeting, PA , PD98059 was from
 .New England Biolabs Beverly, MA and rapamycin
 .was from Calbiochem-Novabiochem La Jolla, CA .
The BIOTRAKe MAPK assay kit including a spe-
cific peptide substrate related to the sequence of the
w xepidermal growth factor receptor 21 and the ECL
detection system were obtained from Amersham In-
 .ternational Buckinghamshire, England . Other chem-
icals were either reagent grade or the best grade
available.
2.2. Assay of the membrane-bound PDE from rat
adipocytes
Isolated adipocytes were prepared by the collage-
nase method from epididymal fat pads of 200–250 g
w xmale Sprague–Dawley rats 22 . The cells were incu-
bated without or with 1 nM insulin for 10 min at
378C in Krebs–Ringer–Hepes–Albumin buffer pH
 .7.4 KRHA containing 20 mgrml bovine serum
albumin and 200 nM adenosine. After the incubation
with insulin, adipocytes were washed twice with
buffer A 10 mM TES, pH 7.0, containing 250 mM
.sucrose and homogenized with a Dounce tissue
 .grinder eight strokes in the same buffer at room
temperature. The membrane-bound fraction obtained
w xfrom isolated adipocytes as described previously 6,9
was suspended in buffer A, pH 7.4, and the PDE
w xactivity was determined 6,9 . In experiments with
inhibitors, cells were preincubated with wortmannin
for 20 min, LY294002 for 20 min, rapamycin for 20
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min or PD98059 for 30 min before the addition of
insulin.
2.3. Immunoblotting of PDE
The membrane-bound fraction obtained from iso-
w xlated adipocytes as described previously 6,9 was
subjected to SDS-PAGE. Thereafter, proteins were
transferred to nitrocellulose and immunoblotted with
either anti-PDE antibody or an aliquot of the anti-
body preparation that had been neutralized by prein-
cubation with the antigenic PDE peptide. Proteins
were visualized by the ECL system.
2.4. PDE phosphorylation in 32P-labeled adipocytes
The isolated adipocytes were incubated with
w32 x  .P orthophosphate 50 mCirml for 90 min at 378C
in KRHA buffer pH 7.4 without inorganic phosphate
containing 200 nM adenosine, 2 mM glucose, and 20
mgrml bovine serum albumin. In the experiment of
wortmannin, the adipocytes were pretreated with
wortmannin for 20 min prior to treatment of insulin.
After 10 min incubation with 1 nM insulin, adipocytes
were washed twice with buffer A and homogenized
in the same buffer containing 0.1 mM calyculin A,
50 mM paranitrophenylphosphate, 0.5 mM phenyl-
methylsulfonyl fluoride, 15 mgrml leupeptin, 15
 .mgrml pepstatin A, 3 mM benzamidine buffer B at
room temperature. Then homogenates were immedi-
ately cooled to 48C and centrifuged 100 000=g, 30
.min, 48C . The membrane-bound fractions were solu-
bilized with 1% Triton X-100 in buffer B. After 1 h,
solubilized proteins were centrifuged 100 000=g, 1
.h, 48C and supernatants were immunoprecipitated
with anti-PDE antibody. To minimize non-specific
precipitation of proteins, supernatants were preincu-
bated with protein G for 20 min at 48C and then
incubated with anti-PDE antibody overnight at 48C.
The immune complexes were precipitated by protein
G and collected by centrifugation. Immunoprecipi-
tated proteins were washed with 1% TritonX-100,
0.1% SDS and 0.1% TritonX-100, 0.1% SDS in 50
mM Hepes pH 7.5 two times each and subjected to
SDS-PAGE in 7.5% gels. The gels were dried and
autoradiographed with intensifying screen at y708C
on Kodak X-Omat AR film or visualized with digital
imaging of Fujix BAS 2000II.
2.5. Phosphorylation of PDE in a cell free system
( )PDE kinase assay
The PDE kinase assay was performed basically as
w xdescribed by Rahn et al. 15 with certain modifica-
tions. Adipocytes were homogenized in buffer C
buffer A supplemented with 0.2 mM EGTA, 2 mM
EDTA, 0.1 mM sodium orthovanadate, 0.1 mM caly-
culin A, 50 mM paranitrophenylphosphate, 0.5 mM
phenylmethylsulfonyl fluoride, 15 mgrml leupeptin,
.15 mgrml pepstatin A and 3 mM benzamidine and
 .centrifuged 100 000=g, 60 min, 48C . The mem-
brane-bound fraction obtained was solubilized with
1% Triton X-100 in buffer D buffer A supplemented
with 5 mM MgCl , 1 mM EDTA, 0.5 mM phenyl-2
methylsulfonyl fluoride, 15 mgrml leupeptin, 15
.mgrml pepstatin A and 3 mM benzamidine and
 .centrifuged 100 000=g, 60 min, 48C . The super-
 .natant fraction solubilized PDE preparation was
used as the substrate in the PDE kinase assay see
.below . For preparation of PDE kinase, adipocytes
incubated without or with 1 nM insulin for 10 min
were washed and homogenized in buffer C. In the
experiment of EGF or IGF-I, the incubation period
was for 5 min. The supernatant fraction 100 000=g,
.60 min, 48C was used as the PDE kinase preparation
 .in the assay see below . For the cell-free assay of
PDE kinase, the kinase preparation was incubated
with the solubilized PDE preparation in the presence
of the ATP mixture 600 mM Hepes, pH 7.5, 10 mM
w 32 xMgCl , 0.3 mM EGTA, 210 mM g- P ATP, and 62
.mM H-89 for 20 min at 308C. In the experiment of
direct effect of wortmannin, Ly294002, heparin, H-7,
CKI-7 and CaCl on PDE kinase, each inhibitor was2
added to the kinase preparation prior to the reaction.
The reaction was terminated by the addition of a stop
solution. Thereafter, the reaction mixture was treated
with anti-PDE antibody, and the immune complexes
were precipitated with protein G, collected by cen-
trifugation. The washed immune complexes were
subjected to SDS-PAGE and autoradiographed or
quantitated with a Fujix BAS 2000II digital analyzer
as described above.
2.6. Assays of MAP kinase and p70 S6K
Adipocytes were incubated with or without 1 nM
insulin, 100 ngrml EGF or 100 nM IGF-I; the
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incubation period was 5 min in the experiments with
MAP kinase and 7 min in those with p70S6K. The
cytosol fraction was prepared as described above, and
the kinases were immunoprecipitated by treatment
with either anti-MAP kinase antibody or anti-p70S6K
antibody. The immunoprecipitates were washed and
resuspended in buffer C. MAP kinase was assayed
with the BIOTRAKe MAPK assay kit as described
w x S6Kby Ferby et al. 23 , whereas p70 was assayed
using the so-called large S6 peptide as substrate as
w xdescribed by Lin and Lawrence 24 .
2.7. Phenyl sepharose column chromatography of
MAP kinase and its assay
An aliquot of the cytosol fraction of adipocytes
stimulated with 1 nM insulin was applied to a phenyl
 .sepharose column 0.7=0.5 cm equilibrated with
buffer C. The column was then washed batch-wise
with the buffer followed by that containing 20 or
40% ethylene glycol. Each fraction was assayed for
PDE kinase and MAP kinase.
3. Results
3.1. Immunoblotting of PDE
PDE was detected as a 140-kDa band when the
membrane-bound fraction from rat adipocytes was
Fig. 1. Immunoblotting assay of PDE. Membrane-bound fractions
from adipocytes were subjected to SDS-PAGE followed by West-
ern blot analysis. The preparations were immunoblotted with
 .either anti-PDE antibody PDE peptide: y or antibody that had
been neutralized by preincubation with the PDE peptide used as
 .antigen PDE peptide: q . Proteins were visualized by ECL
system.
Fig. 2. Insulin-induced phosphorylation of PDE in rat adipocytes.
32  .  .P labeled adipocytes were incubated without y or with qi
1 nM insulin. Solubilized membrane-bound fractions of
adipocytes were immunoprecipitated with either anti-PDE anti-
 . body PDE peptide: y or the neutralized antibody PDE pep-
.tide: q and immunoprecipitates were subjected to SDS-PAGE
followed by autoradiography.
subjected to SDS-PAGE followed by immunoblotting
with anti-PDE antibody that was raised against a
specific synthetic peptide, referred to as PDE peptide
 .see Section 2 . Significantly, no 140-kDa band was
detectable when blotting was done with an aliquot of
the antibody that had been neutralized by preincuba-
 .tion with the antigenic PDE peptide Fig. 1 .
3.2. PDE phosphorylation in 32P-labeled adipocytes
As shown in Fig. 2, insulin considerably stimu-
lated phosphorylation of the 140-kDa protein in cells
incubated with 32P . We assumed that the 140-kDai
band was that of phosphorylated PDE since it was
undetectable when the immunoprecipitation was done
with the antibody neutralized with PDE peptide. The
molecular mass of PDE estimated by this method was
slightly larger than that calculated from the amino
w xacid sequence deduced from PDE cDNA 20 . Fur-
thermore, the anti-PDE antibody effectively immuno-
precipitated PDE activity from the solubilized mem-
brane-bound fraction, effect of which was completely
blocked with the neutralized antibody data not
.shown . We concluded, therefore, that the anti-PDE
antibody raised for our present study was a valid
preparation.
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3.3. Effect of wortmannin on insulin-dependent acti-
˝ation and phosphorylation of PDE in rat fat cells
We examined the effect of a specific inhibitor of
w xPI 3-kinase 14 , wortmannin on insulin-dependent
activation and phosphorylation of PDE in rat fat cells.
Phosphorylation of PDE was induced by 1 nM in-
sulin whereas pretreatment of 32P labeled fat cells
with 100 nM wortmannin completely inhibited the
 .phosphorylation of PDE induced by insulin Fig. 3A .
As for PDE activation, 1 nM insulin activated the
PDE about two times and pretreatment of fat cells
with 100 nM wortmannin completely inhibited the
 .insulin-dependent activation of the PDE Fig. 3B .
The effective concentration of wortmannin on in-
sulin-induced PDE activation was almost the same as
that of the insulin-induced PDE phosphorylation.
3.4. Assay of PDE kinase in a cell-free system
By extending the work initiated by Smith et al.
w x13 , we demonstrated the insulin-dependent phos-
phorylation of PDE in our cell-free system. As shown
in Fig. 4A, PDE kinase extracted from insulin-stimu-
lated adipocytes considerably stimulated phosphory-
lation of the 140-kDa protein, that is, PDE as deter-
mined in the experiment shown above. The level of
phosphorylation by the kinase extracted from the
basal state of adipocytes was very low, and no 140-
kDa band was detectable in either basal or plus-in-
 .Fig. 4. Cell-free assay of PDE kinase. A PDE kinase activity in
the cytosol fraction that had been prepared from basal or insulin-
treated adipocytes was determined by incubation with the solubi-
w 32 xlized PDE preparation in the presence of g- P ATP and other
agents as described under Section 2. The reaction mixture was
 .treated with either anti-PDE antibody PDE peptide: y or the
 .neutralized antibody preparation PDE peptide: q . Immunopre-
cipitates were subjected to SDS-PAGE followed by autoradiog-
 .raphy. B The quantity of PDE in solubilized PDE preparation
was monitored with immunoblotting before PDE kinase assay. In
each lane, equal level of PDE was confirmed.
sulin experiments when immunoprecipitation was
done with the neutralized antibody. The quantity of
PDE in solubilized PDE preparation was monitored
Fig. 3. Effect of wortmannin on insulin-induced phosphorylation and activation of PDE in rat adipocytes. 32P labeled adipocytes werei
 .  .  .incubated with the given concentration of wortmannin for 20 min and then without y or with q 1 nM insulin. A Solubilized
membrane-bound fractions of adipocytes were immunoprecipitated with anti-PDE antibody and immunoprecipitates were subjected to
 .SDS-PAGE followed by autoradiography. B Adipocytes were incubated with the given concentration of wortmannin for 20 min and
 .  .then without closed circle or with open circle 1 nM insulin. PDE activity in membrane-bound fractions was assayed. The results are
shown as mean"SE from three separates experiments.
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by immunoblotting before PDE kinase assay. We
confirmed an equal level of PDE in each lane Fig.
.4B . These data support the view that the effect of
insulin on PDE kinase can be determined in our
cell-free system. Although the data are not shown,
PDE kinase was deactivated when insulin-treated cells
were homogenized in the absence of any phosphatase
 .inhibitors see Section 2 . It would appear, therefore,
that the activated form of PDE kinase was phospho-
w xrylated, as suggested earlier 25,26 .
3.5. Inhibitory effects of wortmannin and LY294002
on insulin-dependent stimulation of PDE kinase
In confirmation of several previous data see Sec-
.tion 4 , insulin-dependent stimulation of PDE kinase
was strongly inhibited in the presence of either 100
 .nM wortmannin or 100 mM LY294002 Fig. 5A .
Ly294002 at 100 mM as well as wortmannin Fig.
.3B inhibited insulin-dependent activation of PDE by
 .85"6.9% mean"SE, ns3 . But neither wort-
mannin nor LY294002 had any direct effect on PDE
 .kinase itself Fig. 10 .
3.6. Inhibitory effects of wortmannin and LY294002
on insulin-dependent stimulation of MAP kinase
The insulin-dependent stimulation of MAP kinase
in adipocytes was effectively blocked in the presence
Fig. 6. Effect of PD98059 on the insulin-dependent activation of
PDE kinase and MAP kinase. Adipocytes were incubated with
 .either 0 or 25 mM PD98059 for 30 min and then without y or
 .  .with 1 nM insulin q . A PDE kinase in the cytosol fraction
was assayed as described in Fig. 5. The values are expressed as
 .mean"SE from three separate experiments. B MAP kinase in
the cytosol fraction was assayed as described in Fig. 5. The
values are expressed as mean"SE from three separate experi-
ments.
of either 100 nM wortmannin or 100 mM LY294002
 .  .Fig. 5B . The concentrations of insulin 1 nM and
the inhibitors used in this set of experiments were
identical to those used above in Fig. 5A. In all these
experiments, the preincubation of cells with the re-
Fig. 5. Effects of wortmannin and LY294002 on the insulin-dependent stimulation of PDE kinase and MAP kinase. Adipocytes were
 .  .  .incubated with the given concentrations of wortmannin open column or LY294002 closed column for 20 min and then without y or
 .  .with 1 nM insulin q . A PDE kinase in the cytosol fraction was assayed as described in Fig. 4. The radioactivity of the 140-kDa band
was quantitatively determined with a Fujix BAS 2000II digital analyzer. The result is shown as mean"SE from three separate
 .experiments. B The assay of MAP kinase was done after the kinase was partially purified by immunoprecipitation with anti-MAP kinase
antibody, as described under Section 2. The values are expressed as mean"SE from three separate experiments.
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spective inhibitors was done for 20 min before the
 .addition of insulin see Section 2 .
3.7. Differential effects of PD98059 on the insulin-
dependent stimulation of PDE kinase and MAP ki-
nase
To test the possibility that MAP kinase might be
involved in the hormone-dependent stimulation of
PDE kinase, we tested the effects of PD98059, a
w xhighly specific inhibitor of MAP kinase 27 , on the
insulin-dependent stimulation of PDE kinase and that
of MAP kinase. As shown in Fig. 6, 25 mM PD98059
had little effect on the insulin-dependent stimulation
 .of PDE kinase Fig. 6A but exhibited a strong
 .inhibitory effect on that of MAP kinase Fig. 6B . As
might be expected, the inhibitor had little effect on
the insulin-dependent stimulation of PDE data not
.shown . In all these experiments, cells were preincu-
bated with PD98059 for 30 min before the addition
 .of insulin see Section 4 .
3.8. Effect of EGF or IGF-I on PDE kinase or MAP
kinase in rat adipocytes
To confirm that MAP kinase is not involved in the
stimulation of PDE kinase, we tested the effect of
Fig. 7. Effect of EGF or IGF-I on PDE kinase or MAP kinase.
Adipocytes were incubated with 1 nM insulin, 100 ngrml EGF
 .or 100 nM IGF-I for 5 min. A PDE kinase in the cytosol
fraction was assayed as described in Fig. 5. The values are
 .expressed as mean"SE from three separate experiments. B
MAP kinase in the cytosol fraction was assayed as described in
Fig. 5. The values are expressed as mean"SE from three sepa-
rate experiments.
Fig. 8. Chromatographic differentiation of PDE kinase and MAP
kinase: experiments with phenyl sepharose. The cytosol prepara-
tion of insulin-treated adipocytes was applied to a phenyl
sepharose column. Subsequently, the column was washed with
buffer and then again with buffer supplemented with 20 or 40%
ethylene glycol. The column elutes were assayed for PDE kinase
 .  .A and MAP kinase B . Note that MAP kinase, but not PDE
kinase, was adsorbed by phenyl sepharose.
EGF or IGF-I on PDE kinase or MAP kinase. While
100 ngrml EGF or 100 nM IGF-I increased MAP
kinase activity greater than or almost equal level to
that of 1 nM insulin, the activation of PDE kinase by
EGF or IGF-I is to lesser extent than that by insulin
 .Fig. 7 . The effect of EGF and IGF-I on PDE is
 .similar to that on PDE kinase data not shown .
These data are consistent with the previous reports
w x24,28,29 .
3.9. E˝idence that PDE kinase is distinct from MAP
kinase: experiments with a column of phenyl
sepharose
As shown in Fig. 8A, when an aliquot of the
cytosol fraction from insulin-stimulated adipocytes
was applied to a column of phenyl sepharose, the
PDE kinase activity appeared in the flow-through
fractions. In contrast, the MAP kinase activity was
adsorbed and later eluted into 20 and 40% ethylene
 .glycol solutions Fig. 8B . These results indicate that
PDE kinase is distinct from MAP kinase.
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3.10. Distinct effects of rapamycin on the insulin
actions on PDE kinase and p70 S6K
It has been shown previously that insulin-depen-
dent stimulation of p70S6K is blocked by both wort-
w x w xmannin 16,30,31 and rapamycin 24,32 . As shown
in Fig. 9A, 25 nM rapamycin had little effect on the
insulin-dependent stimulation of PDE kinase, al-
though it had a strong inhibitory effect on that of
S6K  .p70 Fig. 9B , as reported. As might be expected,
rapamycin had no detectable effect on the insulin-de-
 .pendent stimulation of PDE data not shown .
3.11. E˝idence that PDE kinase is distinct from PI
3-kinase and se˝eral other protein kinases
As shown in Fig. 10, our cell-free tests indicated
that PDE kinase was not directly inhibited by 100 nM
wortmannin, 100 mM Ly294002, 1 mgrml heparin
w xthat inhibits casein kinase II 33 , 20 mM H-7 that
w xinhibits protein kinase C 34 and insulin-stimulated
w xprotein kinase 35,36 , 20 mM CKI-7 that inhibits
w xcasein kinase I 37 , or 5 mM CaCl that inhibits2
Mn-specific protein kinase and protease-activated ki-
w xnase 38,39 . These data indicate that PDE kinase is
Fig. 9. Effect of rapamycin on insulin-dependent activation of
PDE kinase and p70S6K. Adipocytes were incubated with either 0
or 25 nM rapamycin for 20 min followed by the indicated
 .concentrations of insulin. A PDE kinase in the cytosol was
assayed as in Fig. 5. The values are expressed as mean"SE from
 . S6Kthree separate experiments. B The assay of p70 was done
after the kinase was partially purified by immunoprecipitation
with anti-p70S6K antibody. The values are expressed as mean"SE
from three separate experiments.
Fig. 10. Direct effect of wortmannin, Ly294002 and protein
kinase inhibitors on PDE kinase. Adipocytes were incubated
 .  .without y or with q 1 nM insulin. PDE kinase in the cytosol
fraction was assayed in the presence or absence of given concen-
trations of wortmannin, Ly294002, heparin, H-7, CKI-7 or CaCl .2
localized downstream of PI 3-kinase but is not PI
3-kinase itself and that PDE kinase is distinct from
the protein kinases tested.
4. Discussion
The PDE molecule belonging to the PDE gene
family has a conserved catalytic domain in its C-
terminal region and a regulatory domain in its N-
w xterminal region 40 . The catalytic domain of the
insulin-sensitive PDE has an insertion of 44 amino
acids; the presence of this region appears to be
specific for enzymes in the cGMP-inhibited PDE
gene family and also important for identifying indi-
w xvidual members of the family 20 . In our present
study, we custom-made anti-PDE antibody against a
 .synthetic peptide PDE peptide having the amino
acid sequence specific for the insulin-sensitive
adipocyte PDE. The results obtained with this anti-
 .body preparation Figs. 1 and 2 were consistent with
w xthose reported earlier by Degerman et al. 10 and
w xRahn et al. 11,15 .
Since the successful molecular cloning of the in-
w xsulin receptor 41,42 and its primary substrate IRS-1
w x43 , many studies have been performed on the initial
w xphase of insulin action in cells 44 . Earlier studies
revealed that insulin stimulates the so-called MAP
kinase cascade, which is also activated by insulin-like
w xgrowth factor-1 and other growth factors 45,46 .
w xDent et al. 36 suggested that this cascade might be
involved in insulin-dependent stimulation of glyco-
gen synthesis.
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Following the discovery that wortmannin is a
w xhighly specific inhibitor of PI 3-kinase 14 , many
investigators suggested that this may play a pivotal
role in the physiological actions of insulin. Thus, it
was observed that wortmannin at 100 nM effectively
inhibited the insulin-dependent regulation of lipolysis
w x w x14 , PDE and PDE kinase activities 15 , transloca-
w xtion of GLUT4 and glucose transport 14,47,48 ,
S6K w xp70 activity 30,31 and PEPCK gene expression
w x49 . These observations imply that PI 3-kinase may
 .mediate the hormonal signal s to various metabolic
activities.
Subsequently, it was further observed that wort-
mannin inhibited insulin-dependent stimulation of
w xMAP kinase 16–18,28 and glycogen synthase
w x28,31,50 , and insulin-dependent inactivation of
w xglycogen synthase kinase-3 16,18,28,51 . Since
w xwortmannin does not inhibit MAP kinase itself 14 ,
these results suggest that MAP kinase and certain
enzymes involved in the stimulation of glycogen
synthesis might exist downstream of PI 3-kinase.
w xThis possibility was tested by Cheatham et al. 19 in
their experiment with LY294002, a highly specific,
synthetic inhibitor of PI 3-kinase designed to block
w xthe ATP binding to the kinase 52 . The result of their
experiment was negative; they found that, in 3T3
adipocytes, 100 mM LY294002 had a strong in-
hibitory effect on the action of insulin on DNA
synthesis, glucose transporter translocation and
p70S6K, but no inhibitory effect on the hormonal
w xaction on MAP kinase 19 . Accordingly, they con-
cluded that MAP kinase and PI 3-kinase may exist in
separate branches of the cascade of insulin action. In
this connection, by studying the effects of insulin on
several enzymes involved in the glycogen synthesis
w xin muscle, Cross et al. 16 suggested that wortman-
nin may block the hormonal action between Ras and
Raf in the upper stream of the MAP kinase cascade.
The results of our experiments with wortmannin
w xwere consistent with those of others 15–18,28 , indi-
cating that the inhibitor at 100 nM almost completely
inhibited the hormonal effects on both PDE kinase
 .and MAP kinase Figs. 3 and 5 . In contrast, our
results with LY294002 were different from those of
w xCheatham et al. 19 . Our data indicated that
LY294002 at 100 mM almost completely inhibits not
only the hormonal action on PDE kinase but also that
 .on MAP kinase Fig. 5 . These data imply that both
PDE kinase and MAP kinase could be localized
downstream of PI 3-kinase. The reason why our
findings are apparently different from those of
w xCheatham et al. 19 is not immediately clear; how-
ever, a significant factor may be that we exposed
 .cells to the inhibitor for a long period 20 min prior
to incubation with a physiological concentration 1
.  .nM of insulin see Section 2 .
If it is assumed that PDE kinase and MAP kinase
are both localized downstream of PI 3-kinase, the
next question is whether insulin-dependent stimula-
tion of PDE kinase is secondary to that of MAP
kinase. The answer to this was found to be negative
in our experiments with PD98059, a highly specific
w xinhibitor of MAP kinase 27,53 . Our results showed
that insulin can stimulate PDE kinase even under
conditions when the hormonal effect on MAP kinase
 .is strongly attenuated Fig. 6 , thus providing positive
evidence that MAP kinase is not involved in the
insulin-dependent stimulation of PDE kinase. The
data in Fig. 7 further support this notion.
Likewise, the results of our experiments with ra-
pamycin positively prove that PDE kinase is distinct
from p70S6K, and that the insulin-dependent stimula-
tion of the former is not secondary to that of the latter
 . S6K Fig. 9 . As mentioned earlier, p70 like PDE
.kinase or MAP kinase is thought to be localized
downstream of PI 3-kinase, since the hormone-depen-
dent stimulation of p70S6K is inhibited by wortman-
w xnin 30,31 .
The role of MAP kinase in the insulin-dependent
stimulation of glycogen synthase is also controver-
w xsial. As mentioned earlier, Dent et al. 36 reported
that the hormonal effect on glycogen synthesis might
be mediated by MAP kinase; however, the results of
several recent studies indicated that the hormone may
stimulate glycogen synthesis without activating MAP
w xkinase 27,31,50,53 . These new observations suggest
that MAP kinase may not be involved in the insulin-
dependent stimulation of glycogen synthesis, at least
in certain cell types. On the other hand, it has been
well established that MAP kinase plays a critical role
in the transduction of various growth factor signals
w x45 . In fact, it is now generally accepted that ‘MAP
kinase’ stands for ‘mitogen activated protein kinase’
instead of the original name, ‘micro tubule-associated
protein-2 kinase’. Therefore, it may not be surprising
if the kinase in different cell types is stimulated, in
( )H. Onuma et al.rBiochimica et Biophysica Acta 1402 1998 197–208206
response to various stimuli, by different mechanisms
including the well-known MAP kinase cascade in-
w xvolving Ras, Raf-1, etc., 44,45 .
While wortmannin is indeed a PI 3-kinase in-
hibitor, it is suggested that it is not as specific as it
w xhas been reported 54–56 . Thus, the results obtained
in our present study with inhibitors do not positively
prove that PDE kinase, MAP kinase and p70S6K are
localized downstream of PI 3-kinase. Nevertheless,
we tentatively propose that insulin-dependent stimu-
lation of all these three kinases is secondary to the
activation of PI 3-kinase, since we obtained the same
results from the experiments using structurally unre-
lated PI 3-kinase inhibitors, namely wortmannin and
w xLY294002 14,52 . We further suggest that PDE
kinase and MAP kinase or p70S6K are associated with
separate branches of the cascade of insulin action in
adipocytes because the hormone-dependent stimula-
tion of PDE kinase is not secondary to the activation
of the latter two kinases. The branching point of the
cascade may be found either at or below the level of
PI 3-kinase.
In conclusion, our results indicate that PDE kinase
may be a unique enzyme distinct from various other
protein kinases, that the anti-lipolytic mechanism of
insulin, including the hormone-sensitive PDE kinase,
may be localized downstream of PI 3-kinase, and that
MAP kinase may not be involved in the anti-lipolytic
action of insulin in adipocytes.
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